Form D · Pharmaceuticals
BIOPHARM ASIA, INC.
Daquan Village, F4 · CIK 0001080908
Offering snapshot reported Sep 14, 2009 · SEC filing
- Reported sold
- $310K Offering amount: $310K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Sep 3, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2009 | Initial | $310,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-134404
Source: Form D, filed Sep 14, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ziqiang Guo | Director, Executive |
| Yanhua Han | Director |
| Yunlu Yin | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
New Agriculture Development Park
Daquan Village, F4, 134115
Daquan Village, F4, 134115